Clinical Trials Directory

Trials / Completed

CompletedNCT02165930

Effects of Ethanol on Oxycodone Pharmacokinetics in Healthy Volunteers

An Open Label, Single Dose, Randomized, Two Way Crossover Study to Estimate Oxycodone Relative Bioavailability in Healthy Volunteers Following Administration of PF 00345439 Formulation K 40 Mg Under Fasting Conditions With 40% Ethanol Compared With Water

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
17 (actual)
Sponsor
Pain Therapeutics · Industry
Sex
All
Age
21 Years – 55 Years
Healthy volunteers
Accepted

Summary

To Estimate Bioavailability Of 40 Mg Doses Of Pf-00345439 Formulation K Under Fasting Conditions with 40% Ethanol Compared with Water in Healthy Volunteers

Conditions

Interventions

TypeNameDescription
DRUGOxycodoneOne capsule of 40 mg PF-00345439 Formulation K, single dose, administered with water, under fasting conditions
DRUGNaltrexoneSingle dose of 40 mg PF-00345439 under naltrexone block (50 mg of naltrexone administered by mouth 12 hours before, 30 minutes before,and 12 hours after study drug administration).
DRUGOxycodoneOne capsule of 40 mg PF-00345439 Formulation K, single dose, administered with 40% ethanol, under fasting conditions
DRUGNaltrexoneSingle dose of 40 mg PF-00345439 under naltrexone block (50 mg of naltrexone administered by mouth 12 hours before, 30 minutes before, and 12 hours after study drug administration).

Timeline

Start date
2014-07-01
Primary completion
2014-08-01
Completion
2014-08-01
First posted
2014-06-18
Last updated
2016-04-04

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT02165930. Inclusion in this directory is not an endorsement.